CHEMOTHERAPY-INDUCED ANEMIA MANAGEMENT WITH DARBEPOETIN ALFA IN DAILY CLINICAL PRACTICE

被引：0
|
作者：
Cruz, M. A. [1 ]
Bustos, A. [2 ]
Carabantes, F. [3 ]
Diaz, N. [4 ]
Rovira, P. Sanchez [5 ]
Froilan, J. [6 ]
Lorenzo, I. [7 ]
Gasquet, J. A. [7 ]
Alegre, A. [8 ]
机构：
[1] Hosp Virgen Salud, Toledo, Spain
[2] Clin Vistahermosa, Alicante, Spain
[3] Hosp Carlos Haya, Malaga, Spain
[4] Hosp San Juan Alicante, Alicante, Spain
[5] Hosp Jaen, Jaen, Spain
[6] Hosp Barbastro, Barbastro, Spain
[7] Amgen Inc, Barcelona, Spain
[8] Hosp Princesa, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [21] Darbepoetin alfa in the treatment of chemotherapy-induced anaemia
    Wauters, Isabelle
    Vansteenkiste, Johan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (02) : 221 - 230
  • [22] Darbepoetin alfa in chemotherapy - Induced anemia treatment
    Grangeia, Luis
    da Cunha, Marinho
    Baptista, Ana
    Aroso, Manuela
    Moura, Antonio
    Mesquita, Teresa
    ANNALS OF ONCOLOGY, 2006, 17 : 303 - 304
  • [23] Rapid correction of anemia with darbepoetin alfa once every 3 weeks in chemotherapy-induced anemia
    Grangeia, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 384 - 385
  • [24] Clinical trial simulation of a 200-μg fixed dose of darbepoetin alfa in chemotherapy-induced anemia
    Jumbe, N
    Yao, B
    Rovetti, R
    Rossi, G
    Heatherington, AC
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 37 - 44
  • [25] Darbepoetin alfa vs epoetin alfa in chemotherapy-induced anaemia
    Reactions Weekly, 2005, 1056 (1) : 5 - 5
  • [26] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia
    Ben-Hamadi, R
    Duh, MS
    Aggarwal, J
    Henckler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    VALUE IN HEALTH, 2005, 8 (03) : 238 - 238
  • [27] Clinical benefits and risks associated with darbepoetin alfa and epoetin alfa treatment in patients with lung cancer and chemotherapy-induced anemia.
    Tiotiu, Angelica
    Clerc-Urmes, Isabelle
    Chabot, Francois
    Martinet, Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
    Boccia, Ralph
    Malik, Imtiaz A.
    Raja, Vinay
    Kahanic, Stephen
    Liu, Randall
    Lillie, Tom
    Tomita, Dianne
    Clowney, Billy
    Silberstein, Peter
    ONCOLOGIST, 2006, 11 (04): : 409 - 417
  • [29] A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia
    Justice, G
    Kessler, JF
    Jadeja, J
    Campos, L
    Weick, J
    Chen, CF
    Heatherington, AC
    Amado, RG
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1192 - 1198
  • [30] EFFECTIVE MANAGEMENT OF CHEMOTHERAPY-INDUCED ANAEMIA IN CLINICAL PRACTICE USING DARBEPOETIN ALFA: FINAL DATA FROM THE CORRECT II STUDY
    Steinmetz, H. T.
    Lange, O.
    Vehling-Kaiser, U.
    Kindler, M.
    Soeling, U.
    Kuhn, A.
    Hellebrand, E.
    Eggert, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 505 - 506
12345